Search research articles
Contact Us
Filters
Showing results (21-30 of 459) with videos related to
Page
of 46
Sort By:
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
July 25, 2006
Decision models in the evaluation of psychotropic drugs : useful tool or useless toy?
Corrado Barbui, Camilla Lintas
Archives of General Psychiatry
|
July 4, 2007
Publication bias in systematic reviews
Corrado Barbui, Andrea Cipriani
Lancet (London, England)
|
February 27, 2022
Preventing relapse in schizophrenia needs better evidence
Giovanni Ostuzzi, Corrado Barbui
BMJ (Clinical Research Ed.)
|
March 30, 2010
Long term treatment of depression with selective serotonin reuptake inhibitors and newer antidepressants
Steven Reid, Corrado Barbui
Epidemiologia E Psichiatria Sociale
|
June 5, 2002
[A systemic review of the European Agency for the evaluation of medicinal products (EMEA) recommendations on the conduct of clinical trials in psychiatry]
Giuseppe Guaiana, Corrado Barbui
Evidence-Based Mental Health
|
January 19, 2012
Agomelatine and the brave old world of narrative-based medicine
Corrado Barbui, Andrea Cipriani
International Review of Psychiatry (Abingdon, England)
|
October 1, 2005
New generation psychotropics and the automatism of prescribing
Corrado Barbui, Michele Tansella
International Review of Psychiatry (Abingdon, England)
|
October 1, 2005
Psychotropic drug epidemiology: the road travelled, the road ahead
Corrado Barbui, Michele Tansella
Evidence-Based Mental Health
|
January 29, 2008
Adding aripiprazole improves major depressive disorder following incomplete response to antidepressants alone
Andrea Cipriani, Corrado Barbui
The Lancet. Psychiatry
|
November 21, 2021
Expanding access to long-acting antipsychotics in low-income and middle-income countries
Giovanni Ostuzzi, Corrado Barbui
Page
of 46
Search research articles
Search
Showing results (21-30 of 459) with videos related to
Sort By:
Page
of 46
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
July 25, 2006
Decision models in the evaluation of psychotropic drugs : useful tool or useless toy?
Corrado Barbui, Camilla Lintas
Archives of General Psychiatry
|
July 4, 2007
Publication bias in systematic reviews
Corrado Barbui, Andrea Cipriani
Lancet (London, England)
|
February 27, 2022
Preventing relapse in schizophrenia needs better evidence
Giovanni Ostuzzi, Corrado Barbui
BMJ (Clinical Research Ed.)
|
March 30, 2010
Long term treatment of depression with selective serotonin reuptake inhibitors and newer antidepressants
Steven Reid, Corrado Barbui
Epidemiologia E Psichiatria Sociale
|
June 5, 2002
[A systemic review of the European Agency for the evaluation of medicinal products (EMEA) recommendations on the conduct of clinical trials in psychiatry]
Giuseppe Guaiana, Corrado Barbui
Evidence-Based Mental Health
|
January 19, 2012
Agomelatine and the brave old world of narrative-based medicine
Corrado Barbui, Andrea Cipriani
International Review of Psychiatry (Abingdon, England)
|
October 1, 2005
New generation psychotropics and the automatism of prescribing
Corrado Barbui, Michele Tansella
International Review of Psychiatry (Abingdon, England)
|
October 1, 2005
Psychotropic drug epidemiology: the road travelled, the road ahead
Corrado Barbui, Michele Tansella
Evidence-Based Mental Health
|
January 29, 2008
Adding aripiprazole improves major depressive disorder following incomplete response to antidepressants alone
Andrea Cipriani, Corrado Barbui
The Lancet. Psychiatry
|
November 21, 2021
Expanding access to long-acting antipsychotics in low-income and middle-income countries
Giovanni Ostuzzi, Corrado Barbui
Page
of 46